CLINICAL_TRIALS
trial_result
· 2016-03-14
Clinical Trial Update: A Safety and Effectiveness Study of Paliperidone Palmitate in Chinese Patients With Schizophrenia [Phase 4]
Summary
A Phase 4 safety and effectiveness study of paliperidone palmitate in Chinese patients with schizophrenia has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Xian-Janssen Pharmaceutical Ltd. | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED